The number of chlorantraniliprole companies is increasing, and the domestic market will usher in an explosive period

Chlorantraniliprole is a new type of o-carbamidobenzamide insecticide. Bisamide pesticides are currently one of the four major types of pesticides, and in the bisamide pesticide market, chlorantraniliprole occupies the main market share, accounting for about 70%.

Chlorantraniliprole was launched in 2008 and is currently on the market in the United States, Brazil, Canada, China and other regions. Its application crops include soybeans, fruits and vegetables, rice, cotton, corn, etc. Chlorantraniliprole has the advantages of low toxicity, high efficiency, broad insecticidal spectrum, good activity, and long-lasting effect, and has attracted market attention since its launch.

Chlorantraniliprole was launched by DuPont of the United States. As the original research company, DuPont of the United States owns patents such as the core compound of chlorantraniliprole, key intermediate sleeves, and process technology. In 2017, DuPont of the United States transferred the information and property rights of chlorantraniliprole to FMC. The patent compound of chlorantraniliprole expires on August 13, 2023, and the intermediate synthesis patent is valid until 2025.

According to the “2023-2028 China Chlorantraniliprole Industry Market In-depth Research and Development Prospects Forecast Report released by the Industrial Research Center It shows that in recent years, the chlorantraniliprole market has grown strongly, and global sales of chlorantraniliprole will be approximately US$2.45 billion in 2022. It is expected that from 2023 to 2027, with the release of relevant production capacity under construction and the increase of deployed enterprises, the global chlorantraniliprole market will maintain a growth trend, with an average annual compound growth rate of about 4.5%.

Although the patent of chlorantraniliprole has not completely expired, attracted by its prospects, many companies have deployed the chlorantraniliprole industry chain, including Red Sun, Runfeng Co., Ltd., Hailier, Nopson, and Lier Chemical. , Zhongqi Co., Ltd. and other enterprises. As projects under construction come into operation, the production capacity of the chlorantraniliprole industry will expand and market competition will further intensify.

At the same time, the number of chlorantraniliprole-related registrations in China is also growing. According to data from the China Pesticide Information Network, as of September 20, 2023, the number of chlorantraniliprole-related registrations was 78, involving the original drug. , suspension agent, water-dispersible granules, granules and other dosage forms. In order to expand application scenarios and improve insecticidal effects, chlorantraniliprole compound products have received widespread attention from the market. Currently, chlorantraniliprole can be compounded with abamectin, beta-cyhalothrin, pymetrozine, cyfluthrin, deltamethrin, emamectin and other products.

Industry analysts said that chlorantraniliprole is broad-spectrum and highly effective, and is the mainstream product of bisamide insecticides. Our country is a major agricultural country, and the chlorantraniliprole market has huge room for development. As patents expire, domestic companies begin to enter this field. It is expected that by 2023, the number of domestic chlorantraniliprole-related product registrations will exceed 100, but At the same time, domestic companies will also face the risk of intermediate synthesis infringement. Overall, there are both opportunities and challenges for the development of domestic chlorantraniliprole.